Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center

INTRODUCTION: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are rare, life-threatening diseases in which chronically elevated pressure in the pulmonary arteries results in vascular remodeling and right heart failure. Treatment goals are to improve pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulica, Roxana, Fenton, Rebecca, Cefali, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675747/
https://www.ncbi.nlm.nih.gov/pubmed/26411969
http://dx.doi.org/10.1007/s40119-015-0046-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675747/
https://www.ncbi.nlm.nih.gov/pubmed/26411969
http://dx.doi.org/10.1007/s40119-015-0046-y

Ejemplares similares